Drug Discovery용 AI 시장 : 시장 규모, 점유율, 동향, 산업 분석 보고서-제공별, 기술별, 치료 영역별, 용도별, 최종 사용자별, 지역별-시장 예측(2025-2034년)
AI in Drug Discovery Market Size, Share, Trends, Industry Analysis Report: By Offering, By Technology, By Therapeutic Area, By Application, By End User, and By Region - Market Forecast, 2025-2034
상품코드:1605868
리서치사:Polaris Market Research
발행일:2024년 11월
페이지 정보:영문 120 Pages
라이선스 & 가격 (부가세 별도)
한글목차
Polaris Market Research의 최신 조사에 따르면 2034년까지 Drug Discovery용 AI 시장 규모는 264억 9,779만 달러에 이를 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학을 자세히 파악하여, 미래 시장 성장에 관한 분석을 제공합니다.
Drug Discovery용 AI 시장은 기술 진보의 급속한 채용, 헬스 케어 요구 증가, 제약 업계의 역학의 진화에 의해 급속한 성장을 이루고 있습니다. 보다 효율적이고 비용 대비 효과가 높은 의약품 개발 프로세스에 대한 수요 증대가 Drug Discovery용 AI 시장의 수요를 촉진하고 있습니다. 기존의 신약 개발 방법은 시간과 비용이 많이 들고 임상시험 중 실패율도 높았습니다. AI는 잠재적인 의약품 후보의 특정, 유효성과 안전성 예측, 임상시험 디자인 최적화를 가속화함으로써 해결책을 제공합니다. 이를 통해 의약품 개발과 관련된 시간과 비용이 절감되고 시장 개척에 기여합니다. 게다가 만성 질환의 만연과 개별화 의료의 요구의 고조가, Drug Discovery 솔루션에서 AI의 수요를 촉진하고 있습니다. 고령화가 진행되면서 암, 당뇨병, 심혈관 질환 등의 이환율이 상승하는 가운데 보다 효과적인 새로운 치료법의 요구가 높아지고 있습니다. 기계학습과 심층학습을 포함한 AI 기술은 대규모 데이터셋을 분석해 기존 기법으로는 드러나지 않는 패턴을 파악하는 데 특히 적합합니다. 이 능력에 의해, 개개의 환자의 프로파일에 맞춘 표적 치료의 개발이 가능해져, 치료 성적의 향상이나 부작용의 경감을 기대할 수 있습니다.
Drug Discovery용 AI의 도입은 관민 쌍방으로부터 다액의 투자에 의해 촉진되고 있습니다. 전 세계의 정부나 헬스케어 기관은, Drug Discovery 프로세스에 혁명을 가져오는 AI의 가능성을 인식해, 혁신을 촉진하기 위한 연구 개발 이니셔티브에 투자하고 있습니다. 게다가 AI 기술 기업과 제약 대기업과의 콜라보레이션도 증가하고 있어 의약품 개발의 다양한 단계에 AI를 통합하는 것을 목적으로 한 파트너십이 맺어지고 있습니다. 이러한 협력 관계는 또한 계산능력, 클라우드 컴퓨팅, 빅데이터 해석의 진보에 의해 뒷받침되고 있으며, 이들은 Drug Discovery용 AI 용도에 필요한 인프라를 제공하고 있습니다.
Drug Discovery용 AI 시장 보고서 하이라이트
2024년 혁신적인 암 치료에 대한 높은 수요와 AI 주도형 솔루션으로부터 큰 혜택을 받는 암 연구의 복잡성에 의해 Drug Discovery용 AI 시장에서 종양학 부문이 최대의 매출 점유율을 차지했습니다.
제약 및 바이오테크놀러지 기업 부문은 Drug Discovery을 가속화하고, 개발 비용을 삭감하고, 의약품 개발 프로세스의 정밀도와 효율을 높이기 위해서 AI 기술의 채용을 늘리고 있기 때문에 가장 빠른 CAGR로 성장할 것으로 예측됩니다.
2024년에는 북미가 Drug Discovery용 AI 시장에서 가장 큰 시장 점유율을 차지했는데, 이는 고급 의료 인프라, AI 연구에 대한 높은 수준의 투자, 의약품 개발에 AI를 활용하는 주요 제약 및 바이오테크놀러지 기업의 존재 때문입니다.
아시아태평양은 대규모의 다양한 환자 집단이 귀중한 데이터를 제공하고 있으며, Drug Discovery의 혁신을 촉진하는 정부의 지원책이 있기 때문에 예측기간 중 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 Drug Discovery용 AI 시장 인사이트
용도 스냅샷
Drug Discovery 시장 역학
성장 촉진요인 및 기회
제약회사와 AI 프로바이더의 제휴가 시장의 성장 견인
AI 기술의 진보가 시장의 성장 촉진
억제요인 및 과제
데이터의 프라이버시와 보안에 관한 우려가, Drug Discovery용 AI 시장의 성장 제한
PESTEL 분석
Drug Discovery용 AI의 용도 동향
밸류체인 분석
COVID-19의 영향 분석
제5장 세계의 Drug Discovery용 AI 시장 동향 : 제공별
주요 조사 결과
서문
소프트웨어
서비스
제6장 세계의 Drug Discovery용 AI 시장 : 기술별
주요 조사 결과
서문
머신러닝
기타 기술
제7장 세계의 Drug Discovery용 AI 시장 : 치료 영역별
주요 조사 결과
서문
종양학
신경퇴행성 질환
심혈관 질환
대사성 질환
감염증
기타
제8장 세계의 Drug Discovery용 AI 시장 : 용도별
주요 조사 결과
서문
의약품 최적화 및 재사용
전임상시험
기타
제9장 세계의 Drug Discovery용 AI 시장 : 최종 사용자별
주요 조사 결과
서문
제약 및 바이오테크놀러지 기업
계약연구기관
연구센터
학술기관 및 정부기관
제10장 세계의 Drug Discovery용 AI 시장 : 지역별
주요 조사 결과
서문
Drug Discovery용 AI 시장 평가 : 지역별(2020-2034년)
북미
북미 : 제공별(2020-2034년)
북미 : 기술별(2020-2034년)
북미 : 치료 영역별(2020-2034년)
북미 : 용도별(2020-2034년)
북미 : 최종 사용자별(2020-2034년)
미국
캐나다
유럽
유럽 : 제공별(2020-2034년)
유럽 : 기술별(2020-2034년)
유럽 : 치료 영역별(2020-2034년)
유럽 : 용도별(2020-2034년)
유럽 : 최종 사용자별(2020-2034년)
영국
프랑스
독일
이탈리아
스페인
네덜란드
러시아
기타 유럽
아시아태평양
아시아태평양 : 제공별(2020-2034년)
아시아태평양 : 기술별(2020-2034년)
아시아태평양 : 치료 영역별(2020-2034년)
아시아태평양 : 용도별(2020-2034년)
아시아태평양 : 최종 사용자별(2020-2034년)
중국
인도
말레이시아
일본
인도네시아
한국
호주
기타 아시아태평양
중동 및 아프리카
중동 및 아프리카 : 제공별(2020-2034년)
중동 및 아프리카 : 기술별(2020-2034년)
중동 및 아프리카 : 치료 영역별(2020-2034년)
중동 및 아프리카 : 용도별(2020-2034년)
중동 및 아프리카 : 최종 사용자별(2020-2034년)
사우디아라비아
아랍에미리트(UAE)
이스라엘
남아프리카
기타 중동 및 아프리카
라틴아메리카
라틴아메리카 : 제공별(2020-2034년)
라틴아메리카 : 기술별(2020-2034년)
라틴아메리카 : 치료 영역별(2020-2034년)
라틴아메리카 : 용도별(2020-2034년)
라틴아메리카 : 최종사용자별(2020-2034년)
멕시코
브라질
아르헨티나
기타 라틴아메리카
제11장 경쟁 구도
확대 및 인수 분석
확대
인수
제휴, 협업, 합의 및 공개
제12장 기업 프로파일
Atomwise Inc.
BenevolentAI
Berg Health
BioSymetrics, Inc.
CYCLICA
Exscientia
GNS Healthcare
Google
IBM
Insilico Medicine
insitro
AJY
영문 목차
영문목차
The AI in drug discovery market size is expected to reach USD 26,497.79 million by 2034, according to a new study by Polaris Market Research. The report "AI in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Therapeutic Area, By Application, By End User and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa); Segment Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The AI in drug discovery market is experiencing rapid growth, due to rapid adoption of technological advancements, increasing healthcare needs, and evolving pharmaceutical industry dynamics. The escalating demand for more efficient and cost-effective drug development processes is driving demand for the AI in drug discovery market. Traditional drug discovery methods are often time-consuming and expensive, with high failure rates during clinical trials. AI offers a solution by accelerating the identification of potential drug candidates, predicting their efficacy and safety, and optimizing clinical trial designs. This reduces the time and cost associated with drug development, thus contributing to the market growth. Furthermore, the growing prevalence of chronic diseases and the increasing need for personalized medicine is driving demand for AI in drug discovery solutions. With rising aging population and increasing incidence of conditions such as cancer, diabetes, and cardiovascular diseases rises, there is a growing need for new and more effective therapies. AI technologies, including machine learning and deep learning, are particularly well-suited to analyzing large datasets and identifying patterns that may not be apparent through traditional methods. This capability enables the development of targeted therapies tailored to individual patient profiles, improving treatment outcomes and reducing adverse effects.
The adoption of AI in drug discovery is being fueled by substantial investments from both private and public sectors. Governments and healthcare organizations worldwide are recognizing the potential of AI to revolutionize the drug discovery process and are investing in research and development initiatives to foster innovation. Moreover, collaborations between AI technology companies and pharmaceutical giants are also on the rise, with partnerships aimed at integrating AI into various stages of drug development. These collaborations are further supported by advancements in computational power, cloud computing, and big data analytics, which provide the necessary infrastructure for AI applications in drug discovery.
AI in Drug Discovery Market Report Highlights
In 2024, the oncology segment accounted for the largest revenue share in the AI in drug discovery market due to the high demand for innovative cancer treatments and the complexity of cancer research, which benefits significantly from AI-driven solutions.
The pharmaceutical & biotechnology companies segment is anticipated to grow at the fastest CAGR due to their increasing adoption of AI technologies to accelerate drug discovery, reduce development costs, and enhance the precision and efficiency of drug development processes.
In 2024, North America accounted for the largest market share in the AI in drug discovery market due to its advanced healthcare infrastructure, high levels of investment in AI research, and the presence of major pharmaceutical and biotechnology companies leveraging AI for drug development.
The Asia Pacific region is expected to grow at the fastest CAGR in the forecast period due to a large and diverse patient population providing valuable data, and supportive government initiatives fostering innovation in drug discovery.
The global key market players include Atomwise Inc., BenevolentAI, Berg Health (Berg Health acquired by BPGbio Inc.), BioSymetrics, Inc., CYCLICA (Acquired by Recursion Pharmaceuticals), Exscientia, GNS Healthcare (the company Rebranded as Aitia), Google (DeepMind), IBM, Insilico Medicine, insitro.
Polaris Market Research has segmented the AI in drug discovery market report based on offering, technology, therapeutic area, application, end user, and region:
By Offering Outlook (Revenue - USD million, 2020-2034)
Software
Services
By Technology Outlook (Revenue - USD million, 2020-2034)
Machine Learning
Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Other Machine Learning Technologies
Other Technologies
By Therapeutic Area Outlook (Revenue - USD million, 2020-2034)
Oncology
Neurodegenerative Diseases
Cardiovascular Disease
Metabolic Diseases
Infectious Disease
Others
By Application Outlook (Revenue - USD million, 2020-2034)
Drug optimization & repurposing
Preclinical testing
Others
By End User Outlook (Revenue - USD million, 2020-2034)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers
Academic & Government Institutes
By Regional Outlook (Revenue - USD million, 2020-2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global AI in Drug Discovery Market Insights
4.1. AI in Drug Discovery Market - Application Snapshot
4.2. AI in Drug Discovery Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Collaboration Between Pharma Companies and AI Providers is Driving Market Growth
4.2.1.2. The Advancements in AI Technology Are Driving the Market Growth.
4.2.2. Restraints and Challenges
4.2.2.1. Data Privacy and Security Concerns are limiting the growth of AI in Drug Discovery market
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. AI in Drug Discovery Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global AI in Drug Discovery Market, by Offering
5.1. Key Findings
5.2. Introduction
5.2.1. Global AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
5.3. Software
5.3.1. Global AI in Drug Discovery Market, by Software, by Region, 2020-2034 (USD Million)
5.4. Services
5.4.1. Global AI in Drug Discovery Market, by Services , by Region, 2020-2034 (USD Million)
6. Global AI in Drug Discovery Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Global AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
6.3. Machine Learning
6.3.1. Global AI in Drug Discovery Market, by Machine Learning, by Region, 2020-2034 (USD Million)
6.3.2. Deep Learning
6.3.2.1. Global AI in Drug Discovery Market, by Deep Learning, by Region, 2020-2034 (USD Million)
6.3.3. Supervised Learning
6.3.3.1. Global AI in Drug Discovery Market, by Supervised Learning, by Region, 2020-2034 (USD Million)
6.3.4. Reinforcement Learning
6.3.4.1. Global AI in Drug Discovery Market, by Reinforcement Learning, by Region, 2020-2034 (USD Million)
6.3.5. Unsupervised Learning
6.3.5.1. Global AI in Drug Discovery Market, by Unsupervised Learning, by Region, 2020-2034 (USD Million)
6.3.6. Other Machine Learning Technologies
6.3.6.1. Global AI in Drug Discovery Market, by Other Machine Learning Technologies, by Region, 2020-2034 (USD Million)
6.4. Other Technologies
6.4.1. Global AI in Drug Discovery Market, by Other Technologies, by Region, 2020-2034 (USD Million)
7. Global AI in Drug Discovery Market, by Therapeutic Area
7.1. Key Findings
7.2. Introduction
7.2.1. Global AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
7.3. Oncology
7.3.1. Global AI in Drug Discovery Market, by Oncology, by Region, 2020-2034 (USD Million)
7.4. Neurodegenerative Diseases
7.4.1. Global AI in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2020-2034 (USD Million)
7.5. Cardiovascular Disease
7.5.1. Global AI in Drug Discovery Market, by Cardiovascular Disease, by Region, 2020-2034 (USD Million)
7.6. Metabolic Diseases
7.6.1. Global AI in Drug Discovery Market, by Metabolic Diseases, by Region, 2020-2034 (USD Million)
7.7. Infectious Disease
7.7.1. Global AI in Drug Discovery Market, by Infectious Disease, by Region, 2020-2034 (USD Million)
7.8. Others
7.8.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)
8. Global AI in Drug Discovery Market, by Application
8.1. Key Findings
8.2. Introduction
8.2.1. Global AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
8.3. Drug optimization & repurposing
8.3.1. Global AI in Drug Discovery Market, by Drug optimization & repurposing, by Region, 2020-2034 (USD Million)
8.4. Preclinical testing
8.4.1. Global AI in Drug Discovery Market, by Preclinical testing, by Region, 2020-2034 (USD Million)
8.5. Others
8.5.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)
9. Global AI in Drug Discovery Market, by End User
9.1. Key Findings
9.2. Introduction
9.2.1. Global AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
9.3. Pharmaceutical & Biotechnology Companies
9.3.1. Global AI in Drug Discovery Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Million)
9.4. Contract Research Organizations
9.4.1. Global AI in Drug Discovery Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)
9.5. Research Centers
9.5.1. Global AI in Drug Discovery Market, by Research Centers, by Region, 2020-2034 (USD Million)
9.6. Academic & Government Institutes
9.6.1. Global AI in Drug Discovery Market, by Academic & Government Institutes, by Region, 2020-2034 (USD Million)
10. Global AI in Drug Discovery Market, by Geography
10.1. Key Findings
10.2. Introduction
10.2.1. AI in Drug Discovery Market Assessment, By Geography, 2020-2034 (USD Million)
10.3. AI in Drug Discovery Market - North America
10.3.1. North America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.3.2. North America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.3.3. North America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.3.4. North America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.3.5. North America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.3.7. AI in Drug Discovery Market - U.S.
10.3.7.1. U.S.: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.3.7.2. U.S.: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.3.7.3. U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.3.7.4. U.S.: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.3.7.5. U.S.: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.3.8. AI in Drug Discovery Market - Canada
10.3.8.1. Canada: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.3.8.2. Canada: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.3.8.3. Canada: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.3.8.4. Canada: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.3.8.5. Canada: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4. AI in Drug Discovery Market - Europe
10.4.1. Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.2. Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.3. Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.4. Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.5. Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4.6. AI in Drug Discovery Market - UK
10.4.6.1. UK: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.6.2. UK: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.6.3. UK: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.6.4. UK: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.6.5. UK: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4.7. AI in Drug Discovery Market - France
10.4.7.1. France: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.7.2. France: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.7.3. France: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.7.4. France: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.7.5. France: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4.8. AI in Drug Discovery Market - Germany
10.4.8.1. Germany: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.8.2. Germany: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.8.3. Germany: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.8.4. Germany: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.8.5. Germany: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4.9. AI in Drug Discovery Market - Italy
10.4.9.1. Italy: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.9.2. Italy: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.9.3. Italy: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.9.4. Italy: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.9.5. Italy: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4.10. AI in Drug Discovery Market - Spain
10.4.10.1. Spain: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.10.2. Spain: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.10.3. Spain: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.10.4. Spain: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.10.5. Spain: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4.11. AI in Drug Discovery Market - Netherlands
10.4.11.1. Netherlands: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.11.2. Netherlands: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.11.3. Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.11.4. Netherlands: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.11.5. Netherlands: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4.12. AI in Drug Discovery Market - Russia
10.4.12.1. Russia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.12.2. Russia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.12.3. Russia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.12.4. Russia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.12.5. Russia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.4.13. AI in Drug Discovery Market - Rest of Europe
10.4.13.1. Rest of Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.4.13.2. Rest of Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.4.13.3. Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.4.13.4. Rest of Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.4.13.5. Rest of Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5. AI in Drug Discovery Market - Asia Pacific
10.5.1. Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.2. Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.3. Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.4. Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.5. Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5.6. AI in Drug Discovery Market - China
10.5.6.1. China: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.6.2. China: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.6.3. China: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.6.4. China: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.6.5. China: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5.7. AI in Drug Discovery Market - India
10.5.7.1. India: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.7.2. India: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.7.3. India: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.7.4. India: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.7.5. India: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5.8. AI in Drug Discovery Market - Malaysia
10.5.8.1. Malaysia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.8.2. Malaysia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.8.3. Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.8.4. Malaysia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.8.5. Malaysia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5.9. AI in Drug Discovery Market - Japan
10.5.9.1. Japan: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.9.2. Japan: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.9.3. Japan: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.9.4. Japan: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.9.5. Japan: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5.10. AI in Drug Discovery Market - Indonesia
10.5.10.1. Indonesia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.10.2. Indonesia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.10.3. Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.10.4. Indonesia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.10.5. Indonesia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5.11. AI in Drug Discovery Market - South Korea
10.5.11.1. South Korea: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.11.2. South Korea: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.11.3. South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.11.4. South Korea: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.11.5. South Korea: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5.12. AI in Drug Discovery Market - Australia
10.5.12.1. Australia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.12.2. Australia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.12.3. Australia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.12.4. Australia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.12.5. Australia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.5.13. AI in Drug Discovery Market - Rest of Asia Pacific
10.5.13.1. Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.5.13.2. Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.5.13.3. Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.5.13.4. Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.5.13.5. Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.6. AI in Drug Discovery Market - Middle East & Africa
10.6.1. Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.6.2. Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.6.3. Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.6.4. Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.6.5. Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.6.6. AI in Drug Discovery Market - Saudi Arabia
10.6.6.1. Saudi Arabia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.6.6.2. Saudi Arabia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.6.6.3. Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.6.6.4. Saudi Arabia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.6.6.5. Saudi Arabia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.6.7. AI in Drug Discovery Market - UAE
10.6.7.1. UAE: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.6.7.2. UAE: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.6.7.3. UAE: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.6.7.4. UAE: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.6.7.5. UAE: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.6.8. AI in Drug Discovery Market - Israel
10.6.8.1. Israel: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.6.8.2. Israel: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.6.8.3. Israel: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.6.8.4. Israel: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.6.8.5. Israel: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.6.9. AI in Drug Discovery Market - South Africa
10.6.9.1. South Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.6.9.2. South Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.6.9.3. South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.6.9.4. South Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.6.9.5. South Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.6.10. AI in Drug Discovery Market - Rest of Middle East & Africa
10.6.10.1. Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.6.10.2. Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.6.10.3. Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.6.10.4. Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.6.10.5. Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.7. AI in Drug Discovery Market - Latin America
10.7.1. Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.7.2. Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.7.3. Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.7.4. Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.7.5. Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.7.6. AI in Drug Discovery Market - Mexico
10.7.6.1. Mexico: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.7.6.2. Mexico: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.7.6.3. Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.7.6.4. Mexico: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.7.6.5. Mexico: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.7.7. AI in Drug Discovery Market - Brazil
10.7.7.1. Brazil: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.7.7.2. Brazil: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.7.7.3. Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.7.7.4. Brazil: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.7.7.5. Brazil: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.7.8. AI in Drug Discovery Market - Argentina
10.7.8.1. Argentina: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.7.8.2. Argentina: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.7.8.3. Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.7.8.4. Argentina: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.7.8.5. Argentina: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
10.7.9. AI in Drug Discovery Market - Rest of Latin America
10.7.9.1. Rest of Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
10.7.9.2. Rest of Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
10.7.9.3. Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
10.7.9.4. Rest of Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
10.7.9.5. Rest of Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
